Research Overview

Lindsay Frazier's research focuses on three main areas: Biologic and clinical studies of germ cell tumor etiology and treatment across the pediatric-adolescent-young adult spectrum. Prevention policies for both primary and secondary cancer; Treatment of germ cell tumors in pediatric patients. Three cohort studies serve as the basis for this research: Nurses' Health Study I (NHS I), Nurses' Health Study II (NHS II), and the Growing Up Today Study (GUTS). 

Research Background

Lindsay Frazier received her MD from Dartmouth Medical School. She completed an internship and residency at Boston Children's Hospital, and fellowship at Children's Hospital/Dana Farber Cancer Institute.

Education

Medical School

Dartmouth Medical School
1984 Hanover NH

Internship

Pediatrics Boston Children's Hospital
1985 Boston MA

Residency

Pediatrics Boston Children's Hospital
Boston MA

Fellowship

Pediatric Hematology-Oncology Boston Children's Hospital/Dana-Farber Cancer Institute
1989 Boston MA

Graduate School

Harvard School of Public Health
1993 Boston MA

Publications

  1. Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries. Cancer. 2025 May 01; 131(9):e35862. View Abstract
  2. Standard-Dose Versus High-Dose Cisplatin for Intermediate/Poor-Risk Extracranial Malignant Germ Cell Tumors: Re-Analysis of Pediatric Oncology Group 9049 and Children's Cancer Group 8882 Trial Using Updated MaGIC Risk Stratification. Pediatr Blood Cancer. 2025 Jun; 72(6):e31665. View Abstract
  3. Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004-2016) analysis. Int J Gynecol Cancer. 2024 Dec; 34(12):1906-1913. View Abstract
  4. DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res. 2024 Dec 16; 30(24):5681-5692. View Abstract
  5. Comparison of overall and patterns of care in patients with a malignant ovarian germ cell tumor by age in the United States: a National Cancer Database (2004-2016) analysis. Int J Gynecol Cancer. 2024 12 02; 34(12):1906-1913. View Abstract
  6. Exploring clinical markers of Axon degeneration processes in Chemotherapy-induced peripheral neuropathy among young adults receiving vincristine or paclitaxel. BMC Neurol. 2024 Sep 28; 24(1):366. View Abstract
  7. Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative. Pediatr Qual Saf. 2024 Sep-Oct; 9(5):e771. View Abstract
  8. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries. Gynecol Oncol. 2024 07; 186:117-125. View Abstract
  9. Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective. EClinicalMedicine. 2024 Mar; 69:102453. View Abstract
  10. Incidence and survival for childhood cancer by endorsed non-stage prognostic indicators in Australia. Pediatr Blood Cancer. 2024 Apr; 71(4):e30889. View Abstract
  11. Comment on "Comment on 'A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen'". Environ Health Perspect. 2023 Dec; 131(12):128001. View Abstract
  12. Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship. J Clin Oncol. 2024 Feb 20; 42(6):696-706. View Abstract
  13. Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors. Pediatr Blood Cancer. 2023 11; 70(11):e30652. View Abstract
  14. Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children's Oncology Group. J Pediatr Surg. 2023 Dec; 58(12):2399-2404. View Abstract
  15. Children's Oncology Group's 2023 blueprint for research: Germ cell tumors. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30562. View Abstract
  16. Refining the serum miR-371a-3p test for viable germ cell tumor detection. Sci Rep. 2023 06 29; 13(1):10558. View Abstract
  17. Associations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site. Cancer. 2023 10 15; 129(20):3300-3308. View Abstract
  18. Adjuvant chemotherapy does not improve outcome in children with ovarian immature teratoma: A comparative analysis of clinical trial data from the Malignant Germ Cell International Consortium. Pediatr Blood Cancer. 2023 08; 70(8):e30426. View Abstract
  19. Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nat Commun. 2023 05 06; 14(1):2636. View Abstract
  20. Loss to follow-up of minorities, adolescents, and young adults on clinical trials: A report from the Children's Oncology Group. Cancer. 2023 05 15; 129(10):1547-1556. View Abstract
  21. Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic. J Adolesc Young Adult Oncol. 2023 08; 12(4):569-576. View Abstract
  22. Mobile Source Benzene Regulations and Risk of Childhood and Young Adult Hematologic Cancers in Alaska: A Quasi-experimental Study. Epidemiology. 2023 05 01; 34(3):385-388. View Abstract
  23. Unaltered T cell responses to common antigens in individuals with Parkinson's disease. J Neurol Sci. 2023 01 15; 444:120510. View Abstract
  24. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection. Andrology. 2023 05; 11(4):634-640. View Abstract
  25. Advancing clinical and translational research in germ cell tumours (GCT): recommendations from the Malignant Germ Cell International Consortium. Br J Cancer. 2022 11; 127(9):1577-1583. View Abstract
  26. Response to commentary re: Clinicopathologic predictors of outcomes in children with stage I testicular germ cell tumors: A pooled post hoc analysis of trials from the Children's oncology group. J Pediatr Urol. 2022 08; 18(4):513-514. View Abstract
  27. Predicted leukocyte telomere length and risk of germ cell tumours. Br J Cancer. 2022 07; 127(2):301-312. View Abstract
  28. SIOP Strategy 2021-2025: Cure for more, care for all. Pediatr Blood Cancer. 2022 06; 69(6):e29577. View Abstract
  29. Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage. JCO Glob Oncol. 2022 02; 8:e2100266. View Abstract
  30. Malignant extracranial germ cell tumours: A first national report by the South African Children's Cancer Study Group. Pediatr Blood Cancer. 2022 05; 69(5):e29543. View Abstract
  31. Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial. Pediatr Blood Cancer. 2022 02; 69(2):e29451. View Abstract
  32. Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States. Int J Cancer. 2022 02 01; 150(3):482-490. View Abstract
  33. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report. JAMA Oncol. 2021 Oct 01; 7(10):1550-1558. View Abstract
  34. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis. Clin Genitourin Cancer. 2021 12; 19(6):469-479. View Abstract
  35. Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research. JCO Clin Cancer Inform. 2021 09; 5:1034-1043. View Abstract
  36. Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome. J Endocr Soc. 2021 Sep 01; 5(9):bvab098. View Abstract
  37. The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors. Mol Diagn Ther. 2021 05; 25(3):269-271. View Abstract
  38. Safety of Surgical Fertility Preservation Procedures in Children Prior to Hematopoietic Stem Cell Transplant. Transplant Cell Ther. 2021 08; 27(8):696.e1-696.e4. View Abstract
  39. Forecasting essential childhood cancer drug need: An innovative model-based approach. Cancer. 2021 08 15; 127(16):2990-3001. View Abstract
  40. Serum Small RNA Sequencing and miR-375 Assay Do Not Identify the Presence of Pure Teratoma at Postchemotherapy Retroperitoneal Lymph Node Dissection. Eur Urol Open Sci. 2021 Apr; 26:83-87. View Abstract
  41. Neonatal Malignant Disorders: Germ Cell Tumors. Clin Perinatol. 2021 03; 48(1):147-165. View Abstract
  42. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer. 2021 05; 68(5):e28962. View Abstract
  43. Adolescent and young adult neuro-oncology: a comprehensive review. Neurooncol Pract. 2021 Jun; 8(3):236-246. View Abstract
  44. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021 02 05; 371(6529). View Abstract
  45. Developing and Using a Data Commons for Understanding the Molecular Characteristics of Germ Cell Tumors. Methods Mol Biol. 2021; 2195:263-275. View Abstract
  46. Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women. NPJ Breast Cancer. 2020 Nov 23; 6(1):61. View Abstract
  47. Impact of circulating microRNA test (miRNA-371a-3p) on appropriateness of treatment and cost outcomes in patients with Stage I non-seminomatous germ cell tumours. BJU Int. 2021 07; 128(1):57-64. View Abstract
  48. International Trends in the Incidence of Cancer Among Adolescents and Young Adults. J Natl Cancer Inst. 2020 11 01; 112(11):1105-1117. View Abstract
  49. What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool. BMJ Open. 2020 10 26; 10(10):e041901. View Abstract
  50. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium. Cancer. 2021 01 15; 127(2):193-202. View Abstract
  51. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management. J Urol. 2021 Jan; 205(1):137-144. View Abstract
  52. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View Abstract
  53. Contemporary management of ovarian germ cell tumors and remaining controversies. Gynecol Oncol. 2020 08; 158(2):467-475. View Abstract
  54. Development of a Data Model and Data Commons for Germ Cell Tumors. JCO Clin Cancer Inform. 2020 06; 4:555-566. View Abstract
  55. Indoor Ultraviolet Tanning Among U.S. Adolescents and Young Adults: Results From a Prospective Study of Early Onset and Persistence. J Adolesc Health. 2020 10; 67(4):609-611. View Abstract
  56. Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations. JCO Precis Oncol. 2020; 4. View Abstract
  57. Sustainable care for children with cancer: a Lancet Oncology Commission. Lancet Oncol. 2020 04; 21(4):e185-e224. View Abstract
  58. Re: A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. Eur J Cancer. 2020 05; 130:265-266. View Abstract
  59. Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol. 2020 03; 222(3):257.e1-257.e16. View Abstract
  60. Germ Cell Tumors in Adolescents and Young Adults. J Oncol Pract. 2019 08; 15(8):433-441. View Abstract
  61. Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors. Int J Cancer. 2020 05 01; 146(9):2433-2441. View Abstract
  62. a-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium. Cancer. 2019 10 15; 125(20):3649-3656. View Abstract
  63. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis. Lancet Oncol. 2019 07; 20(7):972-983. View Abstract
  64. Reply to Letter to the Editor "Staging of acute leukemia based on central nervous system involvement alone: Is it appropriate?" Pediatr Blood Cancer. 2019 08; 66(8):e27756. View Abstract
  65. Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz008. View Abstract
  66. Sense of Mission and Subsequent Health and Well-Being Among Young Adults: An Outcome-Wide Analysis. Am J Epidemiol. 2019 04 01; 188(4):664-673. View Abstract
  67. Stage at diagnosis for childhood solid cancers in Australia: A population-based study. Cancer Epidemiol. 2019 04; 59:208-214. View Abstract
  68. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol. 2019 04; 20(4):483-493. View Abstract
  69. Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry. Pediatr Blood Cancer. 2019 06; 66(6):e27683. View Abstract
  70. Multicenter pre-operative assessment of pediatric ovarian malignancy. J Pediatr Surg. 2019 Sep; 54(9):1921-1925. View Abstract
  71. Fundamental problems with pediatric adaptive dosing of carboplatin using nuclear-medicine-based estimates of renal function. Pediatr Blood Cancer. 2019 06; 66(6):e27672. View Abstract
  72. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019 01; 20(1):e42-e53. View Abstract
  73. Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature. Semin Oncol. 2019 02; 46(1):48-56. View Abstract
  74. Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. J Clin Oncol. 2019 02 10; 37(5):396-402. View Abstract
  75. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group. Br J Cancer. 2018 10; 119(7):864-872. View Abstract
  76. Klinefelter syndrome in males with germ cell tumors: A report from the Children's Oncology Group. Cancer. 2018 10 01; 124(19):3900-3908. View Abstract
  77. Sodium Thiosulfate and Cisplatin-Induced Hearing Loss. N Engl J Med. 2018 09 20; 379(12):1180-1. View Abstract
  78. Pediatric vincristine-related vocal fold paralysis. Int J Pediatr Otorhinolaryngol. 2018 11; 114:166-169. View Abstract
  79. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults? Gynecol Oncol. 2018 08; 150(2):253-260. View Abstract
  80. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium. Eur J Cancer. 2018 07; 98:30-37. View Abstract
  81. Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials. Cancer Med. 2018 Jul; 7(7):2951-2959. View Abstract
  82. Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study. Pediatr Blood Cancer. 2018 08; 65(8):e27111. View Abstract
  83. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors. Mol Cancer Ther. 2018 05; 17(5):1079-1089. View Abstract
  84. Pediatric Germ Cell Tumors: A Developmental Perspective. Adv Urol. 2018; 2018:9059382. View Abstract
  85. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. Oncologist. 2018 02; 23(2):272. View Abstract
  86. Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study. Lancet Child Adolesc Health. 2018 03; 2(3):173-179. View Abstract
  87. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res. 2018 05 15; 24(10):2251-2261. View Abstract
  88. Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Jan; 16(1):66-97. View Abstract
  89. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study. Pediatr Blood Cancer. 2018 04; 65(4). View Abstract
  90. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706. View Abstract
  91. Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology Group. Br J Cancer. 2018 01; 118(1):121-126. View Abstract
  92. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Gynecol Oncol. 2017 12; 147(3):521-527. View Abstract
  93. T cells from patients with Parkinson's disease recognize a-synuclein peptides. Nature. 2017 06 29; 546(7660):656-661. View Abstract
  94. Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatr Blood Cancer. 2017 Nov; 64(11). View Abstract
  95. The global burden of childhood cancer: Knowing what we do not know. Pediatr Blood Cancer. 2017 08; 64(8). View Abstract
  96. Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group. Genes Chromosomes Cancer. 2017 07; 56(7):548-558. View Abstract
  97. Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. J Clin Oncol. 2017 Apr 10; 35(11):1203-1210. View Abstract
  98. Risk of second malignant neoplasms in women and girls with germ cell tumors. Ann Oncol. 2017 02 01; 28(2):329-332. View Abstract
  99. Body size from birth through adolescence in relation to risk of benign breast disease in young women. Breast Cancer Res Treat. 2017 02; 162(1):139-149. View Abstract
  100. Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review. Pediatr Blood Cancer. 2017 05; 64(5). View Abstract
  101. Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries. Pediatr Blood Cancer. 2017 02; 64(2):321-323. View Abstract
  102. Patient-Reported Measures of Hearing Loss and Tinnitus in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review. J Speech Lang Hear Res. 2016 10 01; 59(5):1247-1252. View Abstract
  103. Ovarian Sex Cord-Stromal Tumors. J Oncol Pract. 2016 10; 12(10):940-946. View Abstract
  104. Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment. Gynecol Oncol. 2016 Nov; 143(2):428-432. View Abstract
  105. Can Big Data Shed Light on the Origins of Pediatric Cancer? Pediatrics. 2016 06; 137(6). View Abstract
  106. Preoperative risk stratification of children with ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1507-12. View Abstract
  107. Risk of second gonadal cancers in women and children with germ cell tumors. Cancer. 2016 07 01; 122(13):2076-82. View Abstract
  108. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7. View Abstract
  109. A systematic review of patient-reported outcome measures of neuropathy in children, adolescents and young adults. Support Care Cancer. 2016 09; 24(9):3723-8. View Abstract
  110. Paediatric extracranial germ-cell tumours. Lancet Oncol. 2016 04; 17(4):e149-e162. View Abstract
  111. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. Lancet Oncol. 2016 04; 17(4):e163-e172. View Abstract
  112. Disparities by Sexual Orientation in Frequent Engagement in Cancer-Related Risk Behaviors: A 12-Year Follow-Up. Am J Public Health. 2016 Apr; 106(4):698-706. View Abstract
  113. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):401-408. View Abstract
  114. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016 Jan 15; 122(2):230-7. View Abstract
  115. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration. J Clin Oncol. 2015 Sep 20; 33(27):3018-28. View Abstract
  116. Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1699-706. View Abstract
  117. Yolk Sac Tumor of the Testis in Infants and Children: A Clinicopathologic Analysis of 33 Cases. Am J Surg Pathol. 2015 Aug; 39(8):1121-31. View Abstract
  118. Milk Consumption after Age 9 Years Does Not Predict Age at Menarche. J Nutr. 2015 Aug; 145(8):1900-8. View Abstract
  119. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control. 2015 Aug; 26(8):1181-7. View Abstract
  120. Sugar-sweetened beverage consumption and age at menarche in a prospective study of US girls. Hum Reprod. 2015 Mar; 30(3):675-83. View Abstract
  121. Impact of central surgical review in a study of malignant germ cell tumors. J Pediatr Surg. 2015 Sep; 50(9):1502-5. View Abstract
  122. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States. J Clin Oncol. 2015 Jan 10; 33(2):195-201. View Abstract
  123. Determining optimal first-line chemotherapy for good and intermediate prognosis testicular germ cell tumors using decision analysis. J Clin Oncol. 2014 Oct 20; 32(30_suppl):209. View Abstract
  124. Reply: Serum microRNA screening for DICER1-associated pleuropulmonary blastoma. Pediatr Blood Cancer. 2014 Dec; 61(12):2331-2. View Abstract
  125. Reply to G. Mangili et al and C. Lhommé et al. J Clin Oncol. 2014 Sep 01; 32(25):2816-7. View Abstract
  126. Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors. Oncologist. 2014 Jul; 19(7):689-92. View Abstract
  127. Quitting the "Cancer Tube": a qualitative examination of the process of indoor tanning cessation. Transl Behav Med. 2014 Jun; 4(2):209-19. View Abstract
  128. Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma. Pediatr Blood Cancer. 2014 Sep; 61(9):1695-7. View Abstract
  129. Masculine boys, feminine girls, and cancer risk behaviors: an 11-year longitudinal study. J Adolesc Health. 2014 Sep; 55(3):373-9. View Abstract
  130. Adolescent carotenoid intake and benign breast disease. Pediatrics. 2014 May; 133(5):e1292-8. View Abstract
  131. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J Pediatr. 2014 Jun; 164(6):1481-5. View Abstract
  132. Prospective study of peripregnancy consumption of peanuts or tree nuts by mothers and the risk of peanut or tree nut allergy in their offspring. JAMA Pediatr. 2014 Feb; 168(2):156-62. View Abstract
  133. Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol. 2014 Feb 10; 32(5):465-70. View Abstract
  134. Milk consumption during teenage years and risk of hip fractures in older adults. JAMA Pediatr. 2014 Jan; 168(1):54-60. View Abstract
  135. Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw. 2014 Jan; 12(1):21-32; quiz 32. View Abstract
  136. Beyond the bench and the bedside: economic and health systems dimensions of global childhood cancer outcomes. Pediatr Blood Cancer. 2014 Mar; 61(3):572-6. View Abstract
  137. Vitamin D deficiency in reproductive age Mongolian women: a cross sectional study. J Steroid Biochem Mol Biol. 2014 Jan; 139:1-6. View Abstract
  138. Vegetable protein and vegetable fat intakes in pre-adolescent and adolescent girls, and risk for benign breast disease in young women. Breast Cancer Res Treat. 2013 Sep; 141(2):299-306. View Abstract
  139. A comparison of migrants to, and women born in, urban Mongolia: demographic, reproductive, anthropometric and lifestyle characteristics. Int Health. 2013 Dec; 5(4):244-50. View Abstract
  140. DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors. BMC Cancer. 2013 Jun 27; 13:313. View Abstract
  141. Disparities in depressive distress by sexual orientation in emerging adults: the roles of attachment and stress paradigms. Arch Sex Behav. 2014 Jul; 43(5):901-16. View Abstract
  142. Influence of hormonal contraceptive use and health beliefs on sexual orientation disparities in Papanicolaou test use. Am J Public Health. 2014 Feb; 104(2):319-25. View Abstract
  143. Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG). Pediatr Blood Cancer. 2013 Oct; 60(10):1602-5. View Abstract
  144. Preadolescent and adolescent risk factors for benign breast disease. J Adolesc Health. 2013 May; 52(5 Suppl):S36-40. View Abstract
  145. Dairy intakes in older girls and risk of benign breast disease in young women. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):670-4. View Abstract
  146. Global challenges in pediatric oncology. Curr Opin Pediatr. 2013 Feb; 25(1):3-15. View Abstract
  147. Updates in the management of ovarian germ cell tumors. Am Soc Clin Oncol Educ Book. 2013. View Abstract
  148. Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer. 2013 Jun; 60(6):1016-21. View Abstract
  149. Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials. Pediatr Blood Cancer. 2013 Apr; 60(4):587-92. View Abstract
  150. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012 Sep; 130(3):e561-7. View Abstract
  151. Scaling up cancer care for children without medical insurance in developing countries: The case of Mexico. Pediatr Blood Cancer. 2013 Feb; 60(2):196-203. View Abstract
  152. Fetal and neonatal germ cell tumors. Semin Fetal Neonatal Med. 2012 Aug; 17(4):222-230. View Abstract
  153. A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1. Am J Med Genet A. 2012 Jun; 158A(6):1414-21. View Abstract
  154. Sexual-orientation disparities in cigarette smoking in a longitudinal cohort study of adolescents. Nicotine Tob Res. 2013 Jan; 15(1):213-22. View Abstract
  155. Management of ovarian and testicular sex cord-stromal tumors in children and adolescents. J Pediatr Hematol Oncol. 2012 May; 34 Suppl 2:S55-63. View Abstract
  156. Breast cancer incidence in Mongolia. Cancer Causes Control. 2012 Jul; 23(7):1047-53. View Abstract
  157. Long-term impact of a chef on school lunch consumption: findings from a 2-year pilot study in Boston middle schools. J Acad Nutr Diet. 2012 Jun; 112(6):927-33. View Abstract
  158. "Accelerated ear-age": a new measure of chemotherapy-induced ototoxicity. Pediatr Blood Cancer. 2012 Nov; 59(5):947-9. View Abstract
  159. An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis. J Pediatr Hematol Oncol. 2012 Mar; 34(2):e69-71. View Abstract
  160. Use of tanning beds and incidence of skin cancer. J Clin Oncol. 2012 May 10; 30(14):1588-93. View Abstract
  161. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 2012 Jun 01; 118(11):2796-803. View Abstract
  162. Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors. Genes Chromosomes Cancer. 2012 Mar; 51(3):266-71. View Abstract
  163. Randomized trial of fortified milk and supplements to raise 25-hydroxyvitamin D concentrations in schoolchildren in Mongolia. Am J Clin Nutr. 2011 Aug; 94(2):578-84. View Abstract
  164. Reproductive health screening disparities and sexual orientation in a cohort study of U.S. adolescent and young adult females. J Adolesc Health. 2011 Nov; 49(5):505-10. View Abstract
  165. Changes in incidence of infant cancer: Analysis of SEER data 1992-2007. J Clin Oncol. 2011 May 20; 29(15_suppl):9542. View Abstract
  166. Prospective study of growth and development in older girls and risk of benign breast disease in young women. Cancer. 2011 Apr 15; 117(8):1612-20. View Abstract
  167. Impact of maternal communication about skin, cervical, and lung cancer prevention on adolescent prevention behaviors. J Adolesc Health. 2011 Jul; 49(1):93-6. View Abstract
  168. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol. 2011 Mar; 258(3):479-85. View Abstract
  169. Decision analysis to compare treatment strategies for Stage I/favorable histology Wilms tumor. Pediatr Blood Cancer. 2010 Jul 01; 54(7):879-84. View Abstract
  170. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 2010 May; 125(5):e1081-7. View Abstract
  171. Adolescent diet in relation to breast cancer risk among premenopausal women. Cancer Epidemiol Biomarkers Prev. 2010 Mar; 19(3):689-96. View Abstract
  172. Sexual orientation and drug use in a longitudinal cohort study of U.S. adolescents. Addict Behav. 2010 May; 35(5):517-21. View Abstract
  173. Metachronous mediastinal seminoma occurring after intracranial germinoma in an adolescent. J Pediatr Hematol Oncol. 2009 Nov; 31(11):861-4. View Abstract
  174. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature. 2009 Aug 13; 460(7257):909-13. View Abstract
  175. Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009 Jun; 123(6):1439-45. View Abstract
  176. Dairy consumption and female height growth: prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1881-7. View Abstract
  177. Maternal gestational weight gain and offspring weight in adolescence. Obstet Gynecol. 2008 Nov; 112(5):999-1006. View Abstract
  178. Red meat consumption during adolescence among premenopausal women and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2146-51. View Abstract
  179. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008 Apr; 50(4):746-51. View Abstract
  180. Child abuse and smoking among young women: the importance of severity, accumulation, and timing. J Adolesc Health. 2008 Jul; 43(1):55-63. View Abstract
  181. Patterns and determinants of physical activity in U.S. adolescents. J Adolesc Health. 2008 Apr; 42(4):369-77. View Abstract
  182. Effects of vitamin D fortified milk on vitamin D status in Mongolian school age children. Asia Pac J Clin Nutr. 2008; 17(1):68-71. View Abstract
  183. Predicting sexual initiation in a prospective cohort study of adolescents. Arch Pediatr Adolesc Med. 2008 Jan; 162(1):55-9. View Abstract
  184. Cancer Prevention, Chapter 54. Nutrition in Pediatrics, Basic Science and Clinical Applications. Drs. Christopher Duggan, John B. Watkins, W. Allan Walker, eds. 2008; in press. View Abstract
  185. Predicting sexual initiation in a prospective cohort of adolescents. Arch Ped Adol Med. 2008; in press.. View Abstract
  186. Pediatric Germ Cell Tumors. Nathan and Oski's Hematology of Infancy and Childhood. Drs. Orkin, Ginburg, Nathan, Look, Fisher and Lux, eds. 2008; in press. View Abstract
  187. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group. Pediatric Blood and Cancer. 2007; in press. View Abstract
  188. Milk consumption and the prepubertal somatotropic axis. Nutr J. 2007 Sep 27; 6:28. View Abstract
  189. Household smoking restrictions and adolescent smoking. Am J Health Promot. 2007 Sep-Oct; 22(1):15-21. View Abstract
  190. Longitudinal relationship between television viewing and leisure-time physical activity during adolescence. Pediatrics. 2007 Feb; 119(2):e314-9. View Abstract
  191. Combined effects of granulocyte colony stimulating factor and radiation. Clin Nucl Med. 2007 Jan; 32(1):39-41. View Abstract
  192. Frequent tanning bed use, weight concerns, and other health risk behaviors in adolescent females (United States). Cancer Causes Control. 2006 Jun; 17(5):679-86. View Abstract
  193. Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study. J Clin Oncol. 2006 Jun 01; 24(16):2544-8. View Abstract
  194. Sun protection practices among offspring of women with personal or family history of skin cancer. Pediatrics. 2006 Apr; 117(4):e688-94. View Abstract
  195. Results of a union-based smoking cessation intervention for apprentice iron workers. Cancer Causes Control. 2006; 17(1):53-61. View Abstract
  196. Results of a union-based smoking cessation intervention for apprentice iron workers (United States). Cancer Causes Control. 2006 Feb; 17(1):53-61. View Abstract
  197. Breast-feeding and overweight in adolescence: within-family analysis [corrected]. Epidemiology. 2006 Jan; 17(1):112-4. View Abstract
  198. Reducing cigarette smoking among working adolescents: results from the SMART study. Cancer Causes Control. 2005 Dec; 16(10):1159-64. View Abstract
  199. Reducing Cigarette Smoking Among Working Adolescents: Results from the SMART Study. Cancer Causes Control. 2005; 16(10):1159-64. View Abstract
  200. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Cancer. 2005 Aug 15; 104(4):841-7. View Abstract
  201. Family dinner and adolescent overweight. Obes Res. 2005 May; 13(5):900-6. View Abstract
  202. High school dietary dairy intake and teenage acne. J Am Acad Dermatol. 2005 Feb; 52(2):207-14. View Abstract
  203. Adult recall of adolescent diet: reproducibility and comparison with maternal reporting. Am J Epidemiol. 2005 Jan 01; 161(1):89-97. View Abstract
  204. State tobacco excise taxes and adolescent smoking behaviors in the United States. J Public Health Manag Pract. 2004 Nov-Dec; 10(6):490-6. View Abstract
  205. Development of a scale to measure adolescents' beliefs and attitudes about postponing sexual initiation. J Adolesc Health. 2004 Nov; 35(5):425.e1-10. View Abstract
  206. The influence of wanting to look like media figures on adolescent physical activity. J Adolesc Health. 2004 Jul; 35(1):41-50. View Abstract
  207. Changing channels for tobacco control with youth: developing an intervention for working teens. Health Educ Res. 2004 Jun; 19(3):250-60. View Abstract
  208. Sexual orientation and tobacco use in a cohort study of US adolescent girls and boys. Arch Pediatr Adolesc Med. 2004 Apr; 158(4):317-22. View Abstract
  209. Adolescent diet and risk of breast cancer. Cancer Causes Control. 2004 Feb; 15(1):73-82. View Abstract
  210. Changing channels for tobacco control with youth: developing an intervention for working teens. Health Educ Res. 2004; 19(3):250-60. View Abstract
  211. The feasibility evaluating a tobacco control intervention for working youth. Tob Control. 2003; 12 Suppl 4:IV34-9. View Abstract
  212. Feasibility of implementing intervention methods in an adolescent worksite tobacco control study. Tob Control. 2003; 12 Suppl 4:IV40-5. View Abstract
  213. Feasibility of implementing intervention methods in an adolescent worksite tobacco control study. Tob Control. 2003 Dec; 12 Suppl 4:IV40-5. View Abstract
  214. Employed adolescents and beliefs about self-efficacy to avoid smoking. Addict Behav. 2003 Jun; 28(4):613-26. View Abstract
  215. Adolescent diet and risk of breast cancer. Breast Cancer Res. 2003; 5(3):R59-64. View Abstract
  216. Adolescent diet and risk of breast cancer. Breast Cancer Res. 2003; 5(3):R59-64. View Abstract
  217. Outcome of childhood malignant non-seminomatous germ cell tumors (MGCT) according to adult International Germ Cell Classification System (IGCCC). American Society of Clinical Oncology. 2003; 3226. View Abstract
  218. Employed adolescents and beliefs about self-efficacy to avoid smoking. Addict Behav. 2003; 28(4):613-26. View Abstract
  219. Smoking, getting drunk, and engaging in bulimic behaviors: in which order are the behaviors adopted? J Am Acad Child Adolesc Psychiatry. 2002 Jul; 41(7):846-53. View Abstract
  220. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics. 2002 Jun; 109(6):1009-14. View Abstract
  221. Prevalence and correlates of pelvic examinations in sexually active female adolescents. Ambul Pediatr. 2002 May-Jun; 2(3):212-7. View Abstract
  222. Adolescents' perceptions of social status: development and evaluation of a new indicator. Pediatrics. 2001 Aug; 108(2):E31. View Abstract
  223. Social influences, social norms, social support, and smoking behavior among adolescent workers. Am J Health Promot. 2001 Jul-Aug; 15(6):414-21. View Abstract
  224. Risk of overweight among adolescents who were breastfed as infants. JAMA. 2001 May 16; 285(19):2461-7. View Abstract
  225. Comparing physical activity questionnaires for youth: seasonal vs annual format. Am J Prev Med. 2001 May; 20(4):282-5. View Abstract
  226. Social influences, social norms, social support, and smoking behavior among adolescent workers. Am J Health Promot. 2001; 15(6):414-21. View Abstract
  227. Cost-effectiveness of colorectal cancer screening. JAMA. 2001; 285(4):407-8. View Abstract
  228. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000 Oct 18; 284(15):1954-61. View Abstract
  229. Relation of childhood diet and body size to menarche and adolescent growth in girls. Am J Epidemiol. 2000 Sep 01; 152(5):446-52. View Abstract
  230. Association of adolescent cigar use with other high-risk behaviors. Pediatrics. 2000 Aug; 106(2):E26. View Abstract
  231. Activity, dietary intake, and weight changes in a longitudinal study of preadolescent and adolescent boys and girls. Pediatrics. 2000 Apr; 105(4):E56. View Abstract
  232. Family dinner and diet quality among older children and adolescents. Arch Fam Med. 2000 Mar; 9(3):235-40. View Abstract
  233. Population-level change in risk factors for cancer. Colditz GA, Hunter D, eds. Cancer Prevention: The Causes and Prevention of Cancer- Volume 1. 2000. View Abstract
  234. Nutrition and cancer. Int Semin Pediatr Gastroenterol Nutr. 2000; 9:10-15. View Abstract
  235. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999 Nov; 10(6):774-7. View Abstract
  236. Weight concerns, weight control behaviors, and smoking initiation. Pediatrics. 1999 Oct; 104(4 Pt 1):918-24. View Abstract
  237. Adolescence and breast carcinoma risk. Cancer. 1999 Jun 01; 85(11):2400-9. View Abstract
  238. Overweight, weight concerns, and bulimic behaviors among girls and boys. J Am Acad Child Adolesc Psychiatry. 1999 Jun; 38(6):754-60. View Abstract
  239. Validation of a youth/adolescent food frequency questionnaire. Prev Med. 1997 Nov-Dec; 26(6):808-16. View Abstract
  240. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control. 1997 Jul; 8(4):649-67. View Abstract
  241. Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin. Med Pediatr Oncol. 1996 Aug; 27(2):69-73. View Abstract
  242. Reproducibility of recall of adolescent diet: Nurses' Health Study (United States). Cancer Causes Control. 1995 Nov; 6(6):499-506. View Abstract
  243. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug; 4(5):567-71. View Abstract
  244. The reproducibility of recall of adolescent diet. Cancer Causes Control. 1995; 6(6):499-506. View Abstract
  245. Should we aim prevention at youth?. In: Stoll B, editor. Reducing the Breast Cancer Risk in Women. 1995. View Abstract
  246. The Treatment of High Grade Pediatric Astrocytomas. In Black PM, editor. Astrocytomas: Diagnosis, Treatment and Biology. 1993; 110-23. View Abstract
  247. New Paradigms for Cancer Prevention. Harvard Public Health Review Spring. 1993; 76. View Abstract
  248. A gamma delta+ T-cell leukemia bearing a novel t(8;14)(q24;q11) translocation demonstrates spontaneous in vitro natural killer-like activity. Blood. 1992 Mar 15; 79(6):1523-31. View Abstract
  249. A gamma/delta+ T cell leukemia bearing a novel t(8;14) (q21:q11) translocation demonstrates spontaneous in vitro natural killer-like activity. Blood. 1992; 79(6):1523-31. View Abstract
  250. The interaction of signal transduction pathways in FRTL5 thyroid follicular cells: studies with stable expression of beta 2-adrenergic receptors. Endocrinology. 1991 Mar; 128(3):1359-68. View Abstract
  251. New perspectives on Raf-1: the involvement of p21ras in the activation of Raf-1 and a potential role for Raf-1 in events occurring later in the cell cycle. Cold Spring Harb Symp Quant Biol. 1991; 56:251-63. View Abstract
  252. The involvement of p21ras in the activation of Raf-1 and a potential role of Raf-1 in events occurring later in the cell cycle. Cold Spring Harbor Quant Biol. 1991; 56:1359-68. View Abstract
  253. Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing. Mol Endocrinol. 1990 Aug; 4(8):1264-76. View Abstract

Contact Lindsay Frazier

Print Profile